June 11, 2019

Ziopharm Oncology Announces FDA Clearance of IND for Sleeping Beauty TCR-T Cell Therapy Trial

Ziopharm Oncology (NASDAQ:ZIOP) has announced that its investigational new drug (IND) application which was submitted by the National Cancer Institute...
December 28, 2018

Ziopharm Oncology Responds to Recent Stock Decline and Clarifies Exclusivity Rights for Clinical Assets

Ziopharm Oncology (Nasdaq:ZIOP) today responded to the recent decline in the Company’s stock price, which accelerated greatly on December 26,...
September 23, 2018

5 Top Weekly NASDAQ Biotech Stocks: Molecular Templates on Top

Molecular Templates, Galectin Therapeutic, Chiasma, ZioPharm Oncology and Caladrius Biosciences were last week's top gainers on the NASDAQ Biotechnology Index.